Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ascorbic Acid + Pazopanib in Metastatic ccRCC
NCT03334409Phase 2Terminated
- Sponsor
- Academic and Community Cancer Research United
- Start
- Feb 2018
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ascorbic acid in clear cell renal cell carcinoma (ccRCC), sponsored by Academic and Community Cancer Research United. Started Feb 2018; status: terminated.
02
Drugs
ascorbic acid
03
Conditions
clear cell renal cell carcinoma (ccRCC)
Beyond the preview
Go deeper on NCT03334409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03334409.